ORIGINAL ARTICLESA new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial
Under an Elsevier user license
open archive
Keywords
dabigatran etexilate
deep vein thrombosis
direct thrombin inhibitor
total hip replacement
total knee replacement
venous thromboembolism
Cited by (0)
Presented as an oral communication at the 18th International Congress on Thrombosis, Ljubljana, Slovenia 20–24 June 2004.
- ***
Study participants are listed at the end of the paper.
Copyright © 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.